Lawrence Steinman, Director of Pasithea Therapeutics KTTA, has filed 4 purchases and 0 sales on the open market. Over the past 12 months that comes to a net purchase of $100K. The latest trade was on 05/01.

LS

LS

Lawrence Steinman

Director

Company

Pasithea Therapeutics KTTA

First filing

23/06/02

Trades

17 trades

Buys / sales

4 / 0

12-month net buying

$100K

Last trade

05/01

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Pasithea TherapeuticsKTTA	Open-market buy	25/11/28	25/12/01	133,333 sh	$0.75	$99,999.75	+200.9%
BioAtlaBCAB	Open-market buy	23/12/19	23/12/19	20,000 sh	$2.05	$41,000	+108.3%
Pasithea TherapeuticsKTTA	Open-market buy	23/06/02	23/06/06	30,000 sh	$0.43	$12,900	+2.3%
Forum MarketsFRMM	Open-market buy	23/06/01	23/06/02	18,000 sh	$1.23	$22,140	+59.7%